135 related articles for article (PubMed ID: 12066133)
1. Antiphospholipid antibodies after surgical exposure to topical bovine thrombin.
Su Z; Izumi T; Thames EH; Lawson JH; Ortel TL
J Lab Clin Med; 2002 Jun; 139(6):349-56. PubMed ID: 12066133
[TBL] [Abstract][Full Text] [Related]
2. Detection of 'antiphospholipid' antibodies: a single chromogenic assay of thrombin generation sensitively detects lupus anticoagulants, anticardiolipin antibodies, plus antibodies binding beta(2)-glycoprotein I and prothrombin.
Sheng Y; Hanly JG; Reddel SW; Kouts S; Guerin J; Koike T; Ichikawa K; Sturgess A; Krilis SA
Clin Exp Immunol; 2001 Jun; 124(3):502-8. PubMed ID: 11472415
[TBL] [Abstract][Full Text] [Related]
3. Identification of thrombin antibodies in patients with antiphospholipid syndrome.
Miesbach W; Matthias T; Scharrer I
Ann N Y Acad Sci; 2005 Jun; 1050():250-6. PubMed ID: 16014540
[TBL] [Abstract][Full Text] [Related]
4. Immunologic impact and clinical outcomes after surgical exposure to bovine thrombin.
Ortel TL; Mercer MC; Thames EH; Moore KD; Lawson JH
Ann Surg; 2001 Jan; 233(1):88-96. PubMed ID: 11141230
[TBL] [Abstract][Full Text] [Related]
5. Development of antibodies to topical bovine thrombin after abdominal hysterectomy. A case report.
Adams JD; Jones S; Brost BC
J Reprod Med; 2001 Oct; 46(10):909-12. PubMed ID: 11725736
[TBL] [Abstract][Full Text] [Related]
6. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
[TBL] [Abstract][Full Text] [Related]
7. A safety review of topical bovine thrombin-induced generation of antibodies to bovine proteins.
Ofosu FA; Crean S; Reynolds MW
Clin Ther; 2009 Apr; 31(4):679-91. PubMed ID: 19446142
[TBL] [Abstract][Full Text] [Related]
8. Development of antibodies to thrombin and factor V with recurrent bleeding in a patient exposed to topical bovine thrombin.
Zehnder JL; Leung LL
Blood; 1990 Nov; 76(10):2011-6. PubMed ID: 2242423
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of beta 2-glycoprotein I-dependent anticardiolipin antibodies in the reproductive autoimmune failure syndrome: correlation with conventional antiphospholipid antibody detection systems.
Aoki K; Dudkiewicz AB; Matsuura E; Novotny M; Kaberlein G; Gleicher N
Am J Obstet Gynecol; 1995 Mar; 172(3):926-31. PubMed ID: 7892887
[TBL] [Abstract][Full Text] [Related]
10. Acquired activated protein C resistance associated with IgG antibodies against beta2-glycoprotein I and prothrombin as a strong risk factor for venous thromboembolism.
Nojima J; Kuratsune H; Suehisa E; Iwatani Y; Kanakura Y
Clin Chem; 2005 Mar; 51(3):545-52. PubMed ID: 15637132
[TBL] [Abstract][Full Text] [Related]
11. A phase 3b, open-label, single-group immunogenicity and safety study of topical recombinant thrombin in surgical hemostasis.
Singla NK; Ballard JL; Moneta G; Randleman CD; Renkens KL; Alexander WA
J Am Coll Surg; 2009 Jul; 209(1):68-74. PubMed ID: 19651065
[TBL] [Abstract][Full Text] [Related]
12. Studies on the interaction of placental anticoagulant protein I, beta 2 glycoprotein 1, and antiphospholipid antibodies in the prothrombinase reaction and in the solid phase anticardiolipin assays.
Pierangeli SS; Dean J; Goldsmith GH; Branch DW; Gharavi A; Harris EN
J Lab Clin Med; 1996 Aug; 128(2):194-201. PubMed ID: 8765215
[TBL] [Abstract][Full Text] [Related]
13. Anti-beta2-glycoprotein I autoantibodies, in vitro thrombin generation, and the antiphospholipid syndrome.
Hanly JG; Smith SA
J Rheumatol; 2000 Sep; 27(9):2152-9. PubMed ID: 10990227
[TBL] [Abstract][Full Text] [Related]
14. [Comparative study of the occurrence of beta-2-glycoprotein I antibodies (anti-beta-2-GPI) and anticardiolipin antibodies (ACA) in the blood of pregnant women].
Fialová L; Mikulíková L; Malbohan I; Benesová O; Zwinger A
Ceska Gynekol; 1999 Jul; 64(4):255-61. PubMed ID: 10568065
[TBL] [Abstract][Full Text] [Related]
15. Detection of anti-bovine beta 2-glycoprotein I antibody in sera from patients with antiphospholipid syndrome.
Nomura M; Okada J; Kondo H
Rheumatol Int; 1995; 15(1):1-8. PubMed ID: 7652460
[TBL] [Abstract][Full Text] [Related]
16. Perioperative topical bovine thrombin exposure is not associated with hemodialysis graft thrombosis.
Vannorsdall MD; Arkel YS; Ku DH; Lucas FL; Himmelfarb J
Kidney Int; 2003 Aug; 64(2):690-6. PubMed ID: 12846767
[TBL] [Abstract][Full Text] [Related]
17. Development of antibodies to human thrombin and factor V in a pediatric patient exposed to topical bovine thrombin.
Lo CY; Jones C; Glader B; Zehnder JL
Pediatr Blood Cancer; 2010 Dec; 55(6):1195-7. PubMed ID: 20979176
[TBL] [Abstract][Full Text] [Related]
18. Some anticardiolipin antibodies recognize a combination of phospholipids with thrombin-modified antithrombin, complement C4b-binding protein, and lipopolysaccharide binding protein.
Arvieux J; Pernod G; Regnault V; Darnige L; Garin J
Blood; 1999 Jun; 93(12):4248-55. PubMed ID: 10361122
[TBL] [Abstract][Full Text] [Related]
19. Anti-beta2-glycoprotein I (GPI) autoantibodies, annexin V binding and the anti-phospholipid syndrome.
Hanly JG; Smith SA
Clin Exp Immunol; 2000 Jun; 120(3):537-43. PubMed ID: 10844535
[TBL] [Abstract][Full Text] [Related]
20. Pregnancy loss and autoantibodies against phospholipid-binding proteins.
Falcón CR; Martinuzzo ME; Forastiero RR; Cerrato GS; Carreras LO
Obstet Gynecol; 1997 Jun; 89(6):975-80. PubMed ID: 9170477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
